Report: Illuminating Invisible Inequities in Healthcare
Racial disparities in U.S. healthcare garnered more intense scrutiny as COVID-19 impacted minority groups at disproportionately high rates. Growing evidence suggests that implicit bias is among the main factors driving these inequities. Despite an urgent need for systemic change, existing research on implicit bias is mostly academic, and finding clear, actionable guidance on what to do is challenging. GLG Social Impact’s first Insights with Impact report, Illuminating Invisible Inequities in Healthcare, provides a roadmap for organizations seeking […]
Biogen’s Aduhelm: An Update on the Commercial Rollout
The Food and Drug Administration’s (FDA’s) approval of Biogen’s Aduhelm (aducanumab) on June 7, 2021, stirred controversy. Hailed as a breakthrough in treating Alzheimer’s disease, the drug targets the buildup of amyloid beta plaques in the brain, which are thought to be a driver of the disease. Yet there remains a question of whether reducing […]
FDA’s Controversial Aduhelm Approval: What Happens Next?
The FDA caught a lot of flak in June when it approved Biogen’s Aduhelm for the treatment of Alzheimer’s. To learn what happens next for Aduhelm with other government stakeholders, Eric Dimise of GLG’s Healthcare Events team spoke with Michael Adelberg, Principal at Faegre Drinker Consulting, where he leads the Healthcare Strategy practice. Prior to […]
The Future of Healthcare in India
For a glimpse into the future of the healthcare in India, it may help to start with an overview of where we are now. The sector is dominated by India’s biggest hospital groups: Apollo, Fortis, Narayana, Manipal, and Max Healthcare. Apollo Hospitals is largest in terms of revenue and owning, managing, or operating 33 hospitals […]
Report | Illuminating Invisible Inequities in Healthcare: Methods for Measuring and Combatting Implicit Racial Bias
Racial disparities in U.S. healthcare garnered more intense scrutiny as COVID-19 impacted minority groups at disproportionately high rates. Growing evidence suggests that implicit bias is among the main factors driving these inequities. Despite an urgent need for systemic change, existing research on implicit bias is mostly academic, and finding clear, actionable guidance on what to do is challenging. GLG Social Impact’s first Insights with Impact report, Illuminating Invisible Inequities in Healthcare, provides a roadmap for organizations seeking […]
Professor Lawrence Gostin on Mask and Vaccine Mandates
On August 10, GLG hosted a roundtable entitled Vaccine and Mask Mandates: Public Health Response to COVID-19 featuring Lawrence Gostin, O’Neill Professor of Global Health Law and Faculty Director of the O’Neill Institute for National and Global Health Law at Georgetown University. Professor Gostin also directs the WHO Center on National and Global Health Law. […]
Why the FDA Was Correct in Approving Biogen’s Aducanumab
The Food and Drug Administration on June 7 approved the first drug in 18 years intended to treat Alzheimer’s disease, aducanumab, despite its advisory committee and Alzheimer’s experts citing a lack of evidence that the drug works. In response, three scientists who served on the advisory committee resigned. To get a handle on the approval […]
Insights from GLG Institute’s 2021 Healthcare Leadership Summit
GLG’s 2021 Healthcare Leadership Summit came during a difficult pandemic year. From developing a vaccine in record time to accelerating technologies and maintaining a sense of community while operating remotely, we have faced unprecedented challenges and breakthroughs as an industry and a society. As we build back and borders reopen, we can create a more […]
Jeb Bush and Martin O’Malley on Reopening After COVID-19
The first vaccines in the United States were given in December 2020, followed by the rollout of what is probably the largest immunization campaign in history. Since that time, approximately 150,424,675 or 45% of Americans have been immunized. In May, President Biden set the goal of delivering at least one shot to 70% of adult […]
COVID Vaccinations in Hong Kong: An Update
On Thursday, 25 March, GLG, in partnership with the American Club, held an informal breakfast discussion with Professor Ivan Hung, co-convenor of the Expert Committee on Clinical Events Assessment Following Covid-19 Immunisation. During the breakfast, Professor Hung shared his candid perspective on the variety of vaccines supplied to Hong Kong. Topics included: Overview of the […]
COVID Vaccinations in Hong Kong: Q and A
On Thursday, 25 March, GLG, in partnership with the American Club, held an informal breakfast discussion with Professor Ivan Hung, co-convenor of the Expert Committee on Clinical Events Assessment Following Covid-19 Immunisation. During the breakfast, Professor Hung shared his candid perspective on the variety of vaccines supplied to Hong Kong. Topics included: Overview of the […]
Biden’s Healthcare Priorities
On March 9, 2021, GLG ran its quarterly Virtual Healthcare Leadership Convene. GLG clients heard from our Network Member experts about a range of topics that included the state of COVID-19 in Europe and the practical fundamentals of diversity, equity, and inclusion, and President Biden’s healthcare agenda. Highlights of the final session, The Outlook for […]